Despite Revenue Decline, Strategic Expansions and Operational Adjustments in Place
Key Financial and Operational Highlights from the Latest Earnings Report
Insights into RAPT Therapeutics' Financial Performance and Strategic Decisions Amidst Clinical Trials
Country | G | S | B | Total |
---|---|---|---|---|
United States | 39 | 41 | 33 | 113 |
China | 38 | 32 | 18 | 88 |
ROC | 20 | 28 | 23 | 71 |
Great Britain | 22 | 21 | 22 | 65 |
Japan | 27 | 14 | 17 | 58 |
Australia | 17 | 7 | 22 | 46 |
Italy | 10 | 10 | 20 | 40 |